Clinical Trial Update: Assessment of Coagulation Factor Levels in Left Ventricular Device (LVAD )Patients Following Temporary Warfarin Reversal With Four Factor Prothrombin Complex Concentrate (4F-PCC) [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating coagulation factor levels in LVAD patients after temporary reversal of warfarin with four-factor prothrombin complex concentrate (4F-PC…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anticoagulation in Lvad Patients
• Heart Failure with Left Ventricular Assist Device Related Anticoagulation Management

Snippet

Sponsor: Brigham and Women's Hospital | Conditions: Anticoagulation, Anticoagulation Reversal | Phase 4 | Status: UNKNOWN